-transparent.png){kind=logo}
Editorial: Epigenetic regulation in cardiovascular diseases, volume II. 2023
Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei, China.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2024,
Frontiers in cardiovascular medicine,
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2022,
Frontiers in endocrinology,
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2023,
Frontiers in pharmacology,
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2023,
Frontiers in endocrinology,
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2021,
Frontiers in cell and developmental biology,
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2024,
Frontiers in immunology,
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2024,
Frontiers in cardiovascular medicine,
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2022,
Frontiers in medicine,
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2023,
Frontiers in immunology,
Suowen Xu, and
Indulekha C L Pillai, and
Christoph D Rau, and
Zhihua Wang
January 2023,
Pharmaceuticals (Basel, Switzerland),
